| |
| |
|
| Insider
Information: |
Orbimed Capital Gp Iii Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
107,768 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$5,679 |
|
|
| Total
Shares |
107,768 |
|
|
| Total
Value |
$5,679 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Glaukos Corp |
GKOS |
Director |
2018-03-02 |
0 |
2018-03-06 |
0 |
Premium* |
|
|
Pieris Pharmaceuticals, Inc. |
PIRS |
See Remarks, 10% Owner |
2018-02-13 |
0 |
2018-04-30 |
38,870 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
10% Owner |
2018-08-03 |
0 |
2018-08-20 |
68,898 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-20 |
4/A |
S |
$9.98 |
$3,072,263 |
I/I |
(307,842) |
68,898 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-20 |
4 |
S |
$9.98 |
$1,550,762 |
I/I |
(155,387) |
69,617 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-16 |
4 |
S |
$9.94 |
$3,640,227 |
I/I |
(366,220) |
71,083 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-16 |
4/A |
S |
$9.94 |
$3,640,227 |
I/I |
(366,220) |
70,364 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-15 |
4 |
S |
$9.93 |
$775,037 |
I/I |
(78,050) |
74,538 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-15 |
4/A |
S |
$9.93 |
$775,037 |
I/I |
(78,050) |
73,819 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-14 |
4/A |
S |
$9.94 |
$208,492 |
I/I |
(20,975) |
74,555 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-14 |
4 |
S |
$9.94 |
$208,492 |
I/I |
(20,975) |
75,274 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-13 |
4/A |
S |
$9.98 |
$867,492 |
I/I |
(86,923) |
74,753 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-13 |
4 |
S |
$9.98 |
$867,492 |
I/I |
(86,923) |
75,472 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-10 |
4 |
S |
$9.96 |
$6,820,538 |
I/I |
(684,793) |
75,573 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-09 |
4 |
S |
$9.86 |
$1,998,380 |
I/I |
(201,343) |
82,033 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-09 |
4 |
OE |
$5.00 |
$325,950 |
I/I |
65,190 |
82,897 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-08 |
4 |
S |
$10.00 |
$4,826,600 |
I/I |
(482,660) |
83,318 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
26,388 |
87,871 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-07 |
4 |
S |
$10.01 |
$506,776 |
I/I |
(50,627) |
87,622 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2018-08-03 |
4 |
S |
$11.71 |
$1,396,921 |
I/I |
(119,293) |
88,100 |
0 |
- |
|
| PIRS |
Pieris Pharmaceuticals, I... |
See Remarks |
– – • |
2018-04-30 |
4 |
S |
$6.35 |
$6,350,000 |
I/I |
(1,000,000) |
38,870 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2018-03-06 |
4 |
S |
$30.01 |
$4,953,274 |
I/I |
(161,321) |
0 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2018-03-05 |
4 |
S |
$32.05 |
$6,831,699 |
I/I |
(210,596) |
1,523 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2018-03-02 |
4 |
S |
$31.92 |
$15,002,219 |
I/I |
(464,583) |
3,511 |
0 |
- |
|
| PIRS |
Pieris Pharmaceuticals, I... |
10% Owner |
– – • |
2018-02-13 |
4 |
S |
$8.98 |
$70,915 |
I/I |
(7,897) |
49,270 |
0 |
- |
|
| PIRS |
Pieris Pharmaceuticals, I... |
10% Owner |
– – • |
2018-02-13 |
4 |
OE |
$4.68 |
$37,671 |
I/I |
7,897 |
49,345 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
